Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Posttranscriptional control of hepatic CEACAM1 3′UTR by human antigen R (HuR) mitigates sterile liver inflammation
Brian Cheng, … , Jerzy W. Kupiec-Weglinski, Kenneth J. Dery
Brian Cheng, … , Jerzy W. Kupiec-Weglinski, Kenneth J. Dery
Published September 23, 2025
Citation Information: JCI Insight. 2025;10(18):e194227. https://doi.org/10.1172/jci.insight.194227.
View: Text | PDF
Research Article Hepatology Immunology Inflammation

Posttranscriptional control of hepatic CEACAM1 3′UTR by human antigen R (HuR) mitigates sterile liver inflammation

  • Text
  • PDF
Abstract

Hepatic ischemia-reperfusion injury (IRI) disrupts cellular signaling pathways and contributes to early allograft dysfunction (EAD) in orthotopic liver transplantation (OLT). In this study, we found that the hepatic RNA binding protein Human Antigen R (HuR) regulated the 3′ untranslated region (UTR) of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (Ceacam1) following ischemic stress. Hepatocyte-specific preinjury HuR-null mice exhibited elevated LDH-5 isoenzyme activity and reduced Ceacam1-S expression, reflecting tissue-specific injury. In situ hybridization demonstrated that the stability of Ceacam1 mRNA depended on HuR. Luciferase assays identified Ceacam1 3′UTR cis-elements responsive to high oxygen tension. HuR-targeting short-activating RNAs (saRNAs) preferentially induced the alternative splicing of Ceacam1-S. Antisense oligos directed to the Ceacam1 3′UTR protected WT mice against acute liver injury. In the clinical arm, increased HuR and CEACAM1 expression were associated with reduced proinflammatory phenotype and a lower incidence of EAD in patients with OLT (n = 164). Human discarded livers with elevated ELAVL1/CEACAM1 levels correlated with improved tissue homeostasis. These findings suggest that HuR regulation of Ceacam1 represents a key determinant of donor tissue quality and offers a potential target for future therapeutic strategies in OLT recipients.

Authors

Brian Cheng, Tristan D. Tibbe, Siyuan Yao, Megan Wei, Zeriel Y. Wong, Taylor Torgerson, Richard Chiu, Aanchal S. Kasargod, Kojiro Nakamura, Monica Cappelletti, Myung Sim, Douglas G. Farmer, Fady Kaldas, Jerzy W. Kupiec-Weglinski, Kenneth J. Dery

×

Figure 7

Hepatic CEACAM1 mRNA expression is associated with ELAVL1 mRNA levels in human OLT.

Options: View larger image (or click on image) Download as PowerPoint
Hepatic CEACAM1 mRNA expression is associated with ELAVL1 mRNA levels in...
(A) Human liver biopsies were collected before (pre-OLT) and after (post-OLT) transplantation. (B) Data workflow for Cohorts 1–3 used for mediation analyses, the regression analyses, and all other clinical analyses. Comparisons between the complete-case mediation analyses and the multiple-imputation mediation analyses established that the complete-case mediation analyses dataset was used for linear regression analyses. (C) Correlation of post-OLT ELAVL1/GAPDH (GA) versus CEACAM1/GA mRNA expression. (D) Post-OLT human liver biopsies were divided into low (n = 35, red) and high (n = 36, blue) CEACAM1 expression groups. (E) Post-OLT CEACAM1 compared with ELAVL1 expression. (F) Correlation of pre-OLT ELAVL1/CEACAM1 to post-OLT proinflammatory MAPK14. (G) Correlation of post-OLT ELAVL1/CEACAM1 to post-OLT MAP3K5 and IL17A. (H) Logistic regression model with CEACAM1 predicting the incidence of EAD, controlling for ELAVL1. (I) The relationship between ELAVL1 and CEACAM1 mediates lower log odds of EAD. C, F, and G were analyzed by t tests of the linear regression coefficients. (D and E) were analyzed by nonparametric Wilcoxon Rank Sum tests. (H) The P value comes from a z-test of the logistic regression model coefficient. *P < 0.05, **P < 0.01, ****P < 0.0001 (data are shown as mean ± SEM).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts